These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12463270)

  • 1. Epidemiology and economic impact of migraine.
    Lipton RB; Stewart WF; Scher AI
    Curr Med Res Opin; 2001; 17 Suppl 1():s4-12. PubMed ID: 12463270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of migraine: societal costs and therapeutic opportunities.
    Lipton RB; Stewart WF; von Korff M
    Neurology; 1997 Mar; 48(3 Suppl 3):S4-9. PubMed ID: 9071263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of migraine. A review of cost to society.
    Lipton RB; Stewart WF; Von Korff M
    Pharmacoeconomics; 1994 Sep; 6(3):215-21. PubMed ID: 10155264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of migraine in Latvia and Lithuania: direct and indirect costs.
    Lublóy Á
    BMC Public Health; 2019 Sep; 19(1):1242. PubMed ID: 31500616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of migraine. A review of its socioeconomic impact.
    Solomon GD; Price KL
    Pharmacoeconomics; 1997; 11 Suppl 1():1-10. PubMed ID: 10168038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of migraine in the United States: disability and economic costs.
    Hu XH; Markson LE; Lipton RB; Stewart WF; Berger ML
    Arch Intern Med; 1999 Apr; 159(8):813-8. PubMed ID: 10219926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and impact of migraine.
    Bigal ME; Lipton RB; Stewart WF
    Curr Neurol Neurosci Rep; 2004 Mar; 4(2):98-104. PubMed ID: 14984680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine: epidemiology, impact, and risk factors for progression.
    Lipton RB; Bigal ME
    Headache; 2005 Apr; 45 Suppl 1():S3-S13. PubMed ID: 15833088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of migraine to society.
    Ferrari MD
    Pharmacoeconomics; 1998 Jun; 13(6):667-76. PubMed ID: 10179702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
    Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
    Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and burden of migraine in the United States: data from the American Migraine Study II.
    Lipton RB; Stewart WF; Diamond S; Diamond ML; Reed M
    Headache; 2001; 41(7):646-57. PubMed ID: 11554952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic-specific estimates from government health surveys.
    Burch R; Rizzoli P; Loder E
    Headache; 2021 Jan; 61(1):60-68. PubMed ID: 33349955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Migraine--a burden for the individual and the society].
    Demarin V; Vuković V
    Acta Med Croatica; 2008 May; 62(2):137-40. PubMed ID: 18710076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of migraine.
    Lipton RB; Bigal ME
    Am J Med; 2005 Mar; 118 Suppl 1():3S-10S. PubMed ID: 15841882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.
    Stewart WF; Lipton RB; Celentano DD; Reed ML
    JAMA; 1992 Jan; 267(1):64-9. PubMed ID: 1727198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS).
    Stokes M; Becker WJ; Lipton RB; Sullivan SD; Wilcox TK; Wells L; Manack A; Proskorovsky I; Gladstone J; Buse DC; Varon SF; Goadsby PJ; Blumenfeld AM
    Headache; 2011; 51(7):1058-77. PubMed ID: 21762134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work-related disability: results from the American migraine study.
    Stewart WF; Lipton RB; Simon D
    Cephalalgia; 1996 Jun; 16(4):231-8; discussion 215. PubMed ID: 8792034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.
    Buse DC; Manack AN; Fanning KM; Serrano D; Reed ML; Turkel CC; Lipton RB
    Headache; 2012; 52(10):1456-70. PubMed ID: 22830411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.